MCK — McKesson Corporation
$1102.81
+$25.76 (+2.39%)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$127.33B
Forward P/E
21.1x
52-Week Range
N/A
MCK Price History
Revenue vs. Net Income
$403B
Revenue · FY2026
Annual. Net margin is shown under each year.
Free Cash Flow
$5.4B
FCF · FY2026
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
42.1%
ROCE · FY2026
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.0x
Assets ÷ liabilities · FY2026
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
0.2%
CapEx · FY2026
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-3.1%
Net buyback · FY2026
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
